Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 192

1.

Author Correction: Elevated faecal 12,13-diHOME concentration in neonates at high risk for asthma is produced by gut bacteria and impedes immune tolerance.

Levan SR, Stamnes KA, Lin DL, Panzer AR, Fukui E, McCauley K, Fujimura KE, McKean M, Ownby DR, Zoratti EM, Boushey HA, Cabana MD, Johnson CC, Lynch SV.

Nat Microbiol. 2019 Nov;4(11):2020. doi: 10.1038/s41564-019-0574-7.

PMID:
31492948
2.

Elevated faecal 12,13-diHOME concentration in neonates at high risk for asthma is produced by gut bacteria and impedes immune tolerance.

Levan SR, Stamnes KA, Lin DL, Panzer AR, Fukui E, McCauley K, Fujimura KE, McKean M, Ownby DR, Zoratti EM, Boushey HA, Cabana MD, Johnson CC, Lynch SV.

Nat Microbiol. 2019 Nov;4(11):1851-1861. doi: 10.1038/s41564-019-0498-2. Epub 2019 Jul 22. Erratum in: Nat Microbiol. 2019 Sep 6;:.

3.

Reply.

Cardet JC, Jiang X, Lu Q, Gerard N, McIntire K, Boushey HA, Castro M, Chinchilli VM, Codispoti CD, Dyer AM, Holguin F, Kraft M, Lazarus S, Lemanske RF, Lugogo N, Mauger D, Moore WC, Moy J, Ortega VE, Peters SP, Smith LJ, Solway J, Sorkness CA, Sumino K, Wechsler ME, Wenzel S, Israel E; AsthmaNet Investigators.

J Allergy Clin Immunol. 2019 Sep;144(3):873-874. doi: 10.1016/j.jaci.2019.05.029. Epub 2019 Jul 9. No abstract available.

PMID:
31300279
4.

Distinct nasal airway bacterial microbiotas differentially relate to exacerbation in pediatric patients with asthma.

McCauley K, Durack J, Valladares R, Fadrosh DW, Lin DL, Calatroni A, LeBeau PK, Tran HT, Fujimura KE, LaMere B, Merana G, Lynch K, Cohen RT, Pongracic J, Khurana Hershey GK, Kercsmar CM, Gill M, Liu AH, Kim H, Kattan M, Teach SJ, Togias A, Boushey HA, Gern JE, Jackson DJ, Lynch SV; National Institute of Allergy and Infectious Diseases–sponsored Inner-City Asthma Consortium.

J Allergy Clin Immunol. 2019 Nov;144(5):1187-1197. doi: 10.1016/j.jaci.2019.05.035. Epub 2019 Jun 13.

5.

Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level.

Lazarus SC, Krishnan JA, King TS, Lang JE, Blake KV, Covar R, Lugogo N, Wenzel S, Chinchilli VM, Mauger DT, Dyer AM, Boushey HA, Fahy JV, Woodruff PG, Bacharier LB, Cabana MD, Cardet JC, Castro M, Chmiel J, Denlinger L, DiMango E, Fitzpatrick AM, Gentile D, Hastie A, Holguin F, Israel E, Jackson D, Kraft M, LaForce C, Lemanske RF Jr, Martinez FD, Moore W, Morgan WJ, Moy JN, Myers R, Peters SP, Phipatanakul W, Pongracic JA, Que L, Ross K, Smith L, Szefler SJ, Wechsler ME, Sorkness CA; National Heart, Lung, and Blood Institute AsthmaNet.

N Engl J Med. 2019 May 23;380(21):2009-2019. doi: 10.1056/NEJMoa1814917. Epub 2019 May 19.

6.

Loss of bronchoprotection with ICS plus LABA treatment, β-receptor dynamics, and the effect of alendronate.

Cardet JC, Jiang X, Lu Q, Gerard N, McIntire K, Boushey HA, Castro M, Chinchilli VM, Codispoti CD, Dyer AM, Holguin F, Kraft M, Lazarus S, Lemanske RF, Lugogo N, Mauger D, Moore WC, Moy J, Ortega VE, Peters SP, Smith LJ, Solway J, Sorkness CA, Sumino K, Wechsler ME, Wenzel S, Israel E; AsthmaNet Investigators.

J Allergy Clin Immunol. 2019 Aug;144(2):416-425.e7. doi: 10.1016/j.jaci.2019.01.049. Epub 2019 Mar 11.

7.

Bacterial biogeography of adult airways in atopic asthma.

Durack J, Huang YJ, Nariya S, Christian LS, Ansel KM, Beigelman A, Castro M, Dyer AM, Israel E, Kraft M, Martin RJ, Mauger DT, Rosenberg SR, King TS, White SR, Denlinger LC, Holguin F, Lazarus SC, Lugogo N, Peters SP, Smith LJ, Wechsler ME, Lynch SV, Boushey HA; National Heart, Lung and Blood Institute’s “AsthmaNet”.

Microbiome. 2018 Jun 9;6(1):104. doi: 10.1186/s40168-018-0487-3.

8.

Corticosteroid and long-acting ß-agonist therapy reduces epithelial goblet cell metaplasia.

Lachowicz-Scroggins ME, Finkbeiner WE, Gordon ED, Yuan S, Zlock L, Bhakta NR, Woodruff PG, Fahy JV, Boushey HA.

Clin Exp Allergy. 2017 Dec;47(12):1534-1545. doi: 10.1111/cea.13015. Epub 2017 Sep 26.

PMID:
28833774
9.

Early Probiotic Supplementation for Eczema and Asthma Prevention: A Randomized Controlled Trial.

Cabana MD, McKean M, Caughey AB, Fong L, Lynch S, Wong A, Leong R, Boushey HA, Hilton JF.

Pediatrics. 2017 Sep;140(3). pii: e20163000. doi: 10.1542/peds.2016-3000. Epub 2017 Aug 7.

10.

Incorporating the airway microbiome into asthma phenotyping: Moving toward personalized medicine for noneosinophilic asthma.

Durack J, Boushey HA, Huang YJ.

J Allergy Clin Immunol. 2018 Jan;141(1):82-83. doi: 10.1016/j.jaci.2017.05.026. Epub 2017 Jun 13. No abstract available.

11.

Lactobacillus johnsonii supplementation attenuates respiratory viral infection via metabolic reprogramming and immune cell modulation.

Fonseca W, Lucey K, Jang S, Fujimura KE, Rasky A, Ting HA, Petersen J, Johnson CC, Boushey HA, Zoratti E, Ownby DR, Levine AM, Bobbit KR, Lynch SV, Lukacs NW.

Mucosal Immunol. 2017 Nov;10(6):1569-1580. doi: 10.1038/mi.2017.13. Epub 2017 Mar 15.

12.

Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment.

Durack J, Lynch SV, Nariya S, Bhakta NR, Beigelman A, Castro M, Dyer AM, Israel E, Kraft M, Martin RJ, Mauger DT, Rosenberg SR, Sharp-King T, White SR, Woodruff PG, Avila PC, Denlinger LC, Holguin F, Lazarus SC, Lugogo N, Moore WC, Peters SP, Que L, Smith LJ, Sorkness CA, Wechsler ME, Wenzel SE, Boushey HA, Huang YJ; National Heart, Lung and Blood Institute's “AsthmaNet”.

J Allergy Clin Immunol. 2017 Jul;140(1):63-75. doi: 10.1016/j.jaci.2016.08.055. Epub 2016 Nov 10.

13.

Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation.

Fujimura KE, Sitarik AR, Havstad S, Lin DL, Levan S, Fadrosh D, Panzer AR, LaMere B, Rackaityte E, Lukacs NW, Wegienka G, Boushey HA, Ownby DR, Zoratti EM, Levin AM, Johnson CC, Lynch SV.

Nat Med. 2016 Oct;22(10):1187-1191. doi: 10.1038/nm.4176. Epub 2016 Sep 12.

14.

Joint effects of pregnancy, sociocultural, and environmental factors on early life gut microbiome structure and diversity.

Levin AM, Sitarik AR, Havstad SL, Fujimura KE, Wegienka G, Cassidy-Bushrow AE, Kim H, Zoratti EM, Lukacs NW, Boushey HA, Ownby DR, Lynch SV, Johnson CC.

Sci Rep. 2016 Aug 25;6:31775. doi: 10.1038/srep31775.

15.

Airway Microbiota and the Implications of Dysbiosis in Asthma.

Durack J, Boushey HA, Lynch SV.

Curr Allergy Asthma Rep. 2016 Jul;16(8):52. doi: 10.1007/s11882-016-0631-8. Review.

PMID:
27393699
16.

The microbiome and development of allergic disease.

Lynch SV, Boushey HA.

Curr Opin Allergy Clin Immunol. 2016 Apr;16(2):165-71. doi: 10.1097/ACI.0000000000000255. Review.

17.

The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.

Huang YJ, Boushey HA.

Ann Am Thorac Soc. 2015 Nov;12 Suppl 2:S176-80. doi: 10.1513/AnnalsATS.201506-319AW.

18.

Vitamin D Supplementation and the Risk of Colds in Patients with Asthma.

Denlinger LC, King TS, Cardet JC, Craig T, Holguin F, Jackson DJ, Kraft M, Peters SP, Ross K, Sumino K, Boushey HA, Jarjour NN, Wechsler ME, Wenzel SE, Castro M, Avila PC; NHLBI AsthmaNet Investigators.

Am J Respir Crit Care Med. 2016 Mar 15;193(6):634-41. doi: 10.1164/rccm.201506-1169OC.

19.

Impact of Age and Sex on Response to Asthma Therapy.

Dunn RM, Lehman E, Chinchilli VM, Martin RJ, Boushey HA, Israel E, Kraft M, Lazarus SC, Lemanske RF, Lugogo NL, Peters SP, Sorkness CA, Szefler S, Wechsler ME; NHLBI Asthma Clinical Research Network.

Am J Respir Crit Care Med. 2015 Sep 1;192(5):551-8. doi: 10.1164/rccm.201503-0426OC.

20.

Pharmacodynamic genome-wide association study identifies new responsive loci for glucocorticoid intervention in asthma.

Wang Y, Tong C, Wang Z, Wang Z, Mauger D, Tantisira KG, Israel E, Szefler SJ, Chinchilli VM, Boushey HA, Lazarus SC, Lemanske RF, Wu R.

Pharmacogenomics J. 2015 Oct;15(5):422-9. doi: 10.1038/tpj.2014.83. Epub 2015 Jan 20.

21.

The microbiome in asthma.

Huang YJ, Boushey HA.

J Allergy Clin Immunol. 2015 Jan;135(1):25-30. doi: 10.1016/j.jaci.2014.11.011. Review.

22.

Genome-wide association study of short-acting β2-agonists. A novel genome-wide significant locus on chromosome 2 near ASB3.

Israel E, Lasky-Su J, Markezich A, Damask A, Szefler SJ, Schuemann B, Klanderman B, Sylvia J, Kazani S, Wu R, Martinez F, Boushey HA, Chinchilli VM, Mauger D, Weiss ST, Tantisira KG; SHARP Investigators.

Am J Respir Crit Care Med. 2015 Mar 1;191(5):530-7. doi: 10.1164/rccm.201408-1426OC.

23.

Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.

Huang YJ, Sethi S, Murphy T, Nariya S, Boushey HA, Lynch SV.

J Clin Microbiol. 2014 Aug;52(8):2813-23. doi: 10.1128/JCM.00035-14. Epub 2014 May 21.

24.

Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial.

Castro M, King TS, Kunselman SJ, Cabana MD, Denlinger L, Holguin F, Kazani SD, Moore WC, Moy J, Sorkness CA, Avila P, Bacharier LB, Bleecker E, Boushey HA, Chmiel J, Fitzpatrick AM, Gentile D, Hundal M, Israel E, Kraft M, Krishnan JA, LaForce C, Lazarus SC, Lemanske R, Lugogo N, Martin RJ, Mauger DT, Naureckas E, Peters SP, Phipatanakul W, Que LG, Sheshadri A, Smith L, Solway J, Sullivan-Vedder L, Sumino K, Wechsler ME, Wenzel S, White SR, Sutherland ER; National Heart, Lung, and Blood Institute’s AsthmaNet.

JAMA. 2014 May;311(20):2083-91. doi: 10.1001/jama.2014.5052.

25.

The microbiome and asthma.

Huang YJ, Boushey HA.

Ann Am Thorac Soc. 2014 Jan;11 Suppl 1:S48-51. doi: 10.1513/AnnalsATS.201306-187MG.

26.

Asthmatics with exacerbation during acute respiratory illness exhibit unique transcriptional signatures within the nasal mucosa.

McErlean P, Berdnikovs S, Favoreto S Jr, Shen J, Biyasheva A, Barbeau R, Eisley C, Barczak A, Ward T, Schleimer RP, Erle DJ, Boushey HA, Avila PC.

Genome Med. 2014 Jan 17;6(1):1. doi: 10.1186/gm520. eCollection 2014.

27.

Plasminogen activator inhibitor-1 in sputum and nasal lavage fluids increases in asthmatic patients during common colds.

Cho SH, Hong SJ, Chen H, Habib A, Cho D, Lee SH, Kang J, Ward T, Boushey HA, Schleimer RP, Avila PC.

J Allergy Clin Immunol. 2014 May;133(5):1465-7, 1467.e1-2. doi: 10.1016/j.jaci.2013.11.009. Epub 2013 Dec 24. No abstract available.

28.

House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection.

Fujimura KE, Demoor T, Rauch M, Faruqi AA, Jang S, Johnson CC, Boushey HA, Zoratti E, Ownby D, Lukacs NW, Lynch SV.

Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):805-10. doi: 10.1073/pnas.1310750111. Epub 2013 Dec 16.

29.

The bronchial microbiome and asthma phenotypes.

Huang YJ, Boushey HA.

Am J Respir Crit Care Med. 2013 Nov 15;188(10):1178-80. doi: 10.1164/rccm.201309-1702ED. No abstract available.

30.

Predictors of response to tiotropium versus salmeterol in asthmatic adults.

Peters SP, Bleecker ER, Kunselman SJ, Icitovic N, Moore WC, Pascual R, Ameredes BT, Boushey HA, Calhoun WJ, Castro M, Cherniack RM, Craig T, Denlinger LC, Engle LL, Dimango EA, Israel E, Kraft M, Lazarus SC, Lemanske RF Jr, Lugogo N, Martin RJ, Meyers DA, Ramsdell J, Sorkness CA, Sutherland ER, Wasserman SI, Walter MJ, Wechsler ME, Chinchilli VM, Szefler SJ; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network.

J Allergy Clin Immunol. 2013 Nov;132(5):1068-1074.e1. doi: 10.1016/j.jaci.2013.08.003. Epub 2013 Sep 29.

31.

Genome-wide association study identifies TH1 pathway genes associated with lung function in asthmatic patients.

Li X, Hawkins GA, Ampleford EJ, Moore WC, Li H, Hastie AT, Howard TD, Boushey HA, Busse WW, Calhoun WJ, Castro M, Erzurum SC, Israel E, Lemanske RF Jr, Szefler SJ, Wasserman SI, Wenzel SE, Peters SP, Meyers DA, Bleecker ER.

J Allergy Clin Immunol. 2013 Aug;132(2):313-20.e15. doi: 10.1016/j.jaci.2013.01.051. Epub 2013 Mar 28.

32.

Strategies for tailoring asthma treatment in adults--reply.

Calhoun WJ, Boushey HA, Ameredes BT; Asthma Clinical Research Network BASALT Trial Investigators.

JAMA. 2013 Jan 9;309(2):136-7. doi: 10.1001/jama.2012.73385. No abstract available.

PMID:
23299598
33.

P2X7-regulated protection from exacerbations and loss of control is independent of asthma maintenance therapy.

Denlinger LC, Manthei DM, Seibold MA, Ahn K, Bleecker E, Boushey HA, Calhoun WJ, Castro M, Chinchili VM, Fahy JV, Hawkins GA, Icitovic N, Israel E, Jarjour NN, King T, Kraft M, Lazarus SC, Lehman E, Martin RJ, Meyers DA, Peters SP, Sheerar D, Shi L, Sutherland ER, Szefler SJ, Wechsler ME, Sorkness CA, Lemanske RF Jr; NHLBI Asthma Clinical Research Network Investigators.

Am J Respir Crit Care Med. 2013 Jan 1;187(1):28-33. doi: 10.1164/rccm.201204-0750OC. Epub 2012 Nov 9.

34.

Development of a standardized approach for environmental microbiota investigations related to asthma development in children.

Fujimura KE, Rauch M, Matsui E, Iwai S, Calatroni A, Lynn H, Mitchell H, Johnson CC, Gern JE, Togias A, Boushey HA, Kennedy S, Lynch SV.

J Microbiol Methods. 2012 Nov;91(2):231-9. doi: 10.1016/j.mimet.2012.08.016. Epub 2012 Sep 4.

35.

Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial.

Calhoun WJ, Ameredes BT, King TS, Icitovic N, Bleecker ER, Castro M, Cherniack RM, Chinchilli VM, Craig T, Denlinger L, DiMango EA, Engle LL, Fahy JV, Grant JA, Israel E, Jarjour N, Kazani SD, Kraft M, Kunselman SJ, Lazarus SC, Lemanske RF, Lugogo N, Martin RJ, Meyers DA, Moore WC, Pascual R, Peters SP, Ramsdell J, Sorkness CA, Sutherland ER, Szefler SJ, Wasserman SI, Walter MJ, Wechsler ME, Boushey HA; Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute.

JAMA. 2012 Sep 12;308(10):987-97. doi: 10.1001/2012.jama.10893.

36.

Clinical expert panel on monitoring potential lung toxicity of inhaled oligonucleotides: consensus points and recommendations.

Alton EW, Boushey HA, Garn H, Green FH, Hodges M, Martin RJ, Murdoch RD, Renz H, Shrewsbury SB, Seguin R, Johnson G, Parry JD, Tepper J, Renzi P, Cavagnaro J, Ferrari N.

Nucleic Acid Ther. 2012 Aug;22(4):246-54. doi: 10.1089/nat.2012.0345. Epub 2012 Jul 18.

37.

Genetic variation in B cell-activating factor of the TNF family (BAFF) and asthma exacerbations among African American subjects.

Kumar R, Williams LK, Kato A, Peterson EL, Favoreto S Jr, Hulse K, Wang D, Beckman K, Thyne S, LeNoir M, Meade K, Lanfear DE, Levin AM, Favro D, Yang JJ, Weiss K, Boushey HA, Grammer L, Avila PC, Burchard EG, Schleimer R.

J Allergy Clin Immunol. 2012 Oct;130(4):996-9.e6. doi: 10.1016/j.jaci.2012.04.047. Epub 2012 Jun 22. No abstract available.

38.

Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locus.

Tantisira KG, Damask A, Szefler SJ, Schuemann B, Markezich A, Su J, Klanderman B, Sylvia J, Wu R, Martinez F, Boushey HA, Chinchilli VM, Mauger D, Weiss ST, Israel E; SHARP Investigators.

Am J Respir Crit Care Med. 2012 Jun 15;185(12):1286-91. doi: 10.1164/rccm.201111-2061OC. Epub 2012 Apr 26.

39.

Asthma outcomes: exacerbations.

Fuhlbrigge A, Peden D, Apter AJ, Boushey HA, Camargo CA Jr, Gern J, Heymann PW, Martinez FD, Mauger D, Teague WG, Blaisdell C.

J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S34-48. doi: 10.1016/j.jaci.2011.12.983. Review.

40.

Significance of the microbiome in obstructive lung disease.

Han MK, Huang YJ, Lipuma JJ, Boushey HA, Boucher RC, Cookson WO, Curtis JL, Erb-Downward J, Lynch SV, Sethi S, Toews GB, Young VB, Wolfgang MC, Huffnagle GB, Martinez FJ.

Thorax. 2012 May;67(5):456-63. doi: 10.1136/thoraxjnl-2011-201183. Epub 2012 Feb 8. Review.

41.

A large subgroup of mild-to-moderate asthma is persistently noneosinophilic.

McGrath KW, Icitovic N, Boushey HA, Lazarus SC, Sutherland ER, Chinchilli VM, Fahy JV; Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute.

Am J Respir Crit Care Med. 2012 Mar 15;185(6):612-9. doi: 10.1164/rccm.201109-1640OC. Epub 2012 Jan 20.

42.

Effect of prenatal indoor pet exposure on the trajectory of total IgE levels in early childhood.

Havstad S, Wegienka G, Zoratti EM, Lynch SV, Boushey HA, Nicholas C, Ownby DR, Johnson CC.

J Allergy Clin Immunol. 2011 Oct;128(4):880-885.e4. doi: 10.1016/j.jaci.2011.06.039. Epub 2011 Aug 5.

43.

Antibiotic prescribing during pediatric ambulatory care visits for asthma.

Paul IM, Maselli JH, Hersh AL, Boushey HA, Nielson DW, Cabana MD.

Pediatrics. 2011 Jun;127(6):1014-21. doi: 10.1542/peds.2011-0218. Epub 2011 May 23.

PMID:
21606155
44.

Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma.

Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J, Woyke T, Allgaier M, Bristow J, Wiener-Kronish JP, Sutherland ER, King TS, Icitovic N, Martin RJ, Calhoun WJ, Castro M, Denlinger LC, Dimango E, Kraft M, Peters SP, Wasserman SI, Wechsler ME, Boushey HA, Lynch SV; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network.

J Allergy Clin Immunol. 2011 Feb;127(2):372-381.e1-3. doi: 10.1016/j.jaci.2010.10.048. Epub 2010 Dec 30.

45.

Tiotropium bromide step-up therapy for adults with uncontrolled asthma.

Peters SP, Kunselman SJ, Icitovic N, Moore WC, Pascual R, Ameredes BT, Boushey HA, Calhoun WJ, Castro M, Cherniack RM, Craig T, Denlinger L, Engle LL, DiMango EA, Fahy JV, Israel E, Jarjour N, Kazani SD, Kraft M, Lazarus SC, Lemanske RF Jr, Lugogo N, Martin RJ, Meyers DA, Ramsdell J, Sorkness CA, Sutherland ER, Szefler SJ, Wasserman SI, Walter MJ, Wechsler ME, Chinchilli VM, Bleecker ER; National Heart, Lung, and Blood Institute Asthma Clinical Research Network.

N Engl J Med. 2010 Oct 28;363(18):1715-26. doi: 10.1056/NEJMoa1008770. Epub 2010 Sep 19.

46.

A trial of clarithromycin for the treatment of suboptimally controlled asthma.

Sutherland ER, King TS, Icitovic N, Ameredes BT, Bleecker E, Boushey HA, Calhoun WJ, Castro M, Cherniack RM, Chinchilli VM, Craig TJ, Denlinger L, DiMango EA, Fahy JV, Israel E, Jarjour N, Kraft M, Lazarus SC, Lemanske RF Jr, Peters SP, Ramsdell J, Sorkness CA, Szefler SJ, Walter MJ, Wasserman SI, Wechsler ME, Chu HW, Martin RJ; National Heart, Lung and Blood Institute's Asthma Clinical Research Network.

J Allergy Clin Immunol. 2010 Oct;126(4):747-53. doi: 10.1016/j.jaci.2010.07.024.

47.

Man's best friend? The effect of pet ownership on house dust microbial communities.

Fujimura KE, Johnson CC, Ownby DR, Cox MJ, Brodie EL, Havstad SL, Zoratti EM, Woodcroft KJ, Bobbitt KR, Wegienka G, Boushey HA, Lynch SV.

J Allergy Clin Immunol. 2010 Aug;126(2):410-2, 412.e1-3. doi: 10.1016/j.jaci.2010.05.042. Epub 2010 Jul 14. No abstract available.

48.

Lactobacillus casei abundance is associated with profound shifts in the infant gut microbiome.

Cox MJ, Huang YJ, Fujimura KE, Liu JT, McKean M, Boushey HA, Segal MR, Brodie EL, Cabana MD, Lynch SV.

PLoS One. 2010 Jan 18;5(1):e8745. doi: 10.1371/journal.pone.0008745.

49.

Interleukin-13-induced mucous metaplasia increases susceptibility of human airway epithelium to rhinovirus infection.

Lachowicz-Scroggins ME, Boushey HA, Finkbeiner WE, Widdicombe JH.

Am J Respir Cell Mol Biol. 2010 Dec;43(6):652-61. doi: 10.1165/rcmb.2009-0244OC. Epub 2010 Jan 15.

50.

Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.

Wechsler ME, Kunselman SJ, Chinchilli VM, Bleecker E, Boushey HA, Calhoun WJ, Ameredes BT, Castro M, Craig TJ, Denlinger L, Fahy JV, Jarjour N, Kazani S, Kim S, Kraft M, Lazarus SC, Lemanske RF Jr, Markezich A, Martin RJ, Permaul P, Peters SP, Ramsdell J, Sorkness CA, Sutherland ER, Szefler SJ, Walter MJ, Wasserman SI, Israel E; National Heart, Lung and Blood Institute's Asthma Clinical Research Network.

Lancet. 2009 Nov 21;374(9703):1754-64. doi: 10.1016/S0140-6736(09)61492-6.

Supplemental Content

Loading ...
Support Center